The National Pharmaceutical Pricing Authority (NPPA) on December 16, 2024, fixed the retail price of the Glimepiride IP 0.5 mg + Voglibose IP 0.2mg + Metformin Hydrochloride IP 500mg (as sustained release form).
The following has been stated:
The retail price for the Glimepiride IP 0.5 mg + Voglibose IP 0.2mg + Metformin Hydrochloride IP 500mg (as sustained release form) for M/s Windlass Biotech Ltd. (Manufacturer) & M/s Mankind Pharma ltd (Marketer) will be Rs. 9.12/-.
[Notification No. 19(4310)/2024/DP/NPPA/Div.II]